ロード中...
SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
BACKGROUND: Gliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perh...
保存先:
| 出版年: | Cancer Cell Int |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694905/ https://ncbi.nlm.nih.gov/pubmed/33292262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01675-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|